Incidence of and risk factors for suspected COVID-19 reinfection in Kyoto City: a population-based epidemiological study

[1]  Gheyath K Nasrallah,et al.  Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections , 2022, The New England journal of medicine.

[2]  D. Weiss,et al.  Reduced Odds of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Vaccination Among New York City Adults, July 2021–November 2021 , 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  J. Dushoff,et al.  Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa , 2022, Science.

[4]  Y. Matsumura,et al.  Analysis of a city‐wide COVID‐19 prevention strategy for aged‐care facilities during third and fifth waves of COVID‐19 in Kyoto City, Kyoto, Japan , 2022, Influenza and other respiratory viruses.

[5]  S. van der Werf,et al.  Impact of the Omicron variant on SARS-CoV-2 reinfections in France, March 2021 to February 2022 , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[6]  Y. Maor,et al.  Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine , 2022, Nature Communications.

[7]  L. Manzoli,et al.  Risk of SARS-CoV-2 Reinfection 18 Months After Primary Infection: Population-Level Observational Study , 2022, Frontiers in Public Health.

[8]  M. Helfand,et al.  Risk for Reinfection After SARS-CoV-2: A Living, Rapid Review for American College of Physicians Practice Points on the Role of the Antibody Response in Conferring Immunity Following SARS-CoV-2 Infection , 2022, Annals of Internal Medicine.

[9]  N. Andrews,et al.  Disease severity during SARS-COV-2 reinfection: a nationwide study , 2022, The Journal of Infection.

[10]  K. Brown,et al.  Protective effect of a first SARS-CoV-2 infection from reinfection: a matched retrospective cohort study using PCR testing data in England , 2022, Epidemiology and Infection.

[11]  H. Vennema,et al.  Increased risk of infection with SARS-CoV-2 Omicron BA.1 compared with Delta in vaccinated and previously infected individuals, the Netherlands, 22 November 2021 to 19 January 2022 , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[12]  N. Andrews,et al.  Evaluation of disease severity during SARS-COV-2 reinfection, January 2020 to April 2021, England: an observational study , 2022, Journal of Infection.

[13]  P. Maes,et al.  Considerable escape of SARS-CoV-2 Omicron to antibody neutralization , 2021, Nature.

[14]  L. Lo Muzio,et al.  SARS-CoV-2 Reinfection Is a New Challenge for the Effectiveness of Global Vaccination Campaign: A Systematic Review of Cases Reported in Literature , 2021, International journal of environmental research and public health.

[15]  J. Montaner,et al.  Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older Adults , 2021, medRxiv.

[16]  K. Bruxvoort,et al.  Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients , 2021, Clinical Microbiology and Infection.

[17]  I. Grotto,et al.  Effectiveness of BNT162b2 mRNA COVID-19 vaccine against acquisitions of SARS-CoV-2 among health care workers in long-term care facilities: a prospective cohort study , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  X. Shu,et al.  Comprehensive Characterization of COVID-19 Patients with Repeatedly Positive SARS-CoV-2 Tests Using a Large U.S. Electronic Health Record Database , 2021, medRxiv.

[19]  K. Mølbak,et al.  Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study , 2021, The Lancet.

[20]  D. Altmann,et al.  Risk of SARS-CoV-2 reinfection after natural infection , 2021, The Lancet.

[21]  Joshua B. Singer,et al.  Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study , 2021, The Lancet. Public health.

[22]  J. Malek,et al.  Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  B. Cao,et al.  Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity , 2020, Clinical Microbiology and Infection.

[24]  P. Candoli,et al.  Assessing coronavirus disease 2019 (COVID-19) transmission to healthcare personnel: The global ACT-HCP case-control study , 2020, Infection Control & Hospital Epidemiology.

[25]  J. Tang,et al.  Setting the criteria for SARS-CoV-2 reinfection – six possible cases , 2020, Journal of Infection.